CURRENT UNDERSTANDING ON PATHOGENESIS AND EFFECTIVE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE IB WITH EMPAGLIFLOZIN: NEW INSIGHTS COMING FROM DIABETES FOR ITS POTENTIAL IMPLICATIONS IN OTHER METABOLIC DISORDERS

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders

Glycogen storage type SAFFRON 2020 Ib (GSDIb) is a rare inborn error of metabolism caused by glucose-6-phosphate transporter (G6PT, SLC37A4) deficiency.G6PT defect results in excessive accumulation of glycogen and fat in the liver, kidney, and intestinal mucosa and into both glycogenolysis and gluconeogenesis impairment.Clinical features include he

read more


Public perceptions of Lyme disease and climate change in southern Manitoba, Canada: making a case for strategic decoupling of climate and health messages

Abstract Background Despite scientific evidence that climate change has profound and far reaching implications for public health, translating this knowledge in a manner that supports citizen engagement, applied decision-making, and behavioural change can be challenging.This is especially true for complex vector-borne zoonotic diseases such as Lyme

read more